In mid-January, India began a serious bet on its 1.38 billion people.
Healthcare, front-line workers and the elderly were the first to be eligible, followed by people over the age of 45 in April and then adults aged 1
This latest enlargement, which covers about 43% of the population, has proved to be a critical point.
(Open https://tmsnrt.rs/3x9LYjpin external browser to see interactive graphics.)
Following an increase in COVID-19 infections across the country in April, Prime Minister Narendra Modi accelerated plans to expand the program and opened May 1 vaccinations for people between the ages of 18 and 45.
The decision has led people in this age group, who make up 600 million of the population, to rush to register on the government’s CoWIN vaccination website. It is critical that there is no corresponding increase in vaccine supplies.
As of June 4, India had given at least one dose to about 50 million people between the ages of 18 and 44, representing only 8% of this population.
In addition to the difficulties, there was a gap in the privileges of introducing vaccinations, with hospitals charging different prices for the same vaccine. Some hospitals in affluent areas have sold a shot of Covishield, made in India, for 1,800 rupees ($ 25) a dose, almost double the 950 rupees charged elsewhere.
Also, the urban Indians received shots faster than those living in the countryside. This means that vaccines remain inaccessible to a large part of the population who cannot afford it or have little or no access to private hospitals.
IMPACTOR OF THE VACCINE
India, the world’s largest maker of polio, diphtheria and other vaccines, sold or donated more than 66 million COVID-19 vaccines to 95 countries by mid-April.
But as infections began to rise in India in mid-March, the noise of vaccines at home has also increased. India has now begun importing vaccines and is also expecting donations from the United States.
The government expects vaccine supplies to improve significantly from June. It is expected to produce enough photos by December to inoculate all of its 950 million adults, although those between the ages of 18 and 45 will be last on the priority list.
Several states in India have begun phasing out travel and business restrictions after declining in recent weeks. However, health experts have warned that cases could increase again once most countries reopen, and have called for faster vaccinations.
As of June 8, less than 4% of India’s adult population had received the required two doses of vaccine. Almost 14% received at least one dose and less than a tenth of 18-45 year olds were sown from this group.
Our standards: Thomson Reuters’ principles of trust.